Breaking News Instant updates and real-time market news.

GBT

Global Blood Therapeutics

$37.35

0.45 (1.22%)

, NVO

Novo Nordisk

$34.23

0.21 (0.62%)

07:34
03/21/17
03/21
07:34
03/21/17
07:34

Global Blood Therapeutics coverage assumed with an Outperform at Wedbush

Wedbush analyst Liana Moussatos says that Global Blood Therapeutics' (GBT) GBT440 drug can become the standard of care for sickle cell disease, and he thinks that the stock has not risen adequately following speculation that the company had been approached by Novo Nordisk(NVO) about a takeover. The analyst thinks that the company could be acquired for $73-$87 per share, versus its current price of around $37. Target $73.

GBT

Global Blood Therapeutics

$37.35

0.45 (1.22%)

NVO

Novo Nordisk

$34.23

0.21 (0.62%)

  • 23

    Mar

GBT Global Blood Therapeutics
$37.35

0.45 (1.22%)

01/04/17
JPMS
01/04/17
INITIATION
Target $25
JPMS
Overweight
Global Blood Therapeutics initiated with an Overweight at JPMorgan
JPMorgan analyst Cory Kasimov started Global Blood Therapeutics with an Overweight rating and $25 price target. If successful, the company's GBT440 would be the first new sickle cell disease therapy approved in two decades, Kasimov tells investors in a research note. He's "encouraged" by the Phase 1/2 data to date and thinks the recent share selloff creates a long-term buying opportunity.
01/04/17
01/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Guggenheim analyst Robert Cihra initiated Apple (AAPL) with a Buy rating and $140 price target, stating that while iPhones have slowed to now being cyclical he thinks the company can stay a step ahead of commoditization by maintaining its lead in software with iOS and processing with the Ax chip. 2. JPMorgan analyst Cory Kasimov started Global Blood Therapeutics (GBT) with an Overweight rating and $25 price target. If successful, the company's GBT440 would be the first new sickle cell disease therapy approved in two decades, Kasimov tells investors. 3. Needham analyst Laura Martin initiated Priceline (PCLN) with a Buy and a $1,800 price target due to its market lading position, history of execution, and OTA ecosystem competitive advantages. 4. Canaccord analyst Richard Close initiated Teladoc (TDOC) with a Buy rating and $24 price target. Close said Teladoc is the first mover, industry leader and the only publicly traded telemedicine company. 5. Guggenheim analyst Robert Cihra initiated Tesla (TSLA) with a Buy rating and $280 price target, as he acknowledges it faces a number of risks but also has "nearly open-ended growth disrupting the trillion-dollar auto market." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/01/17
NOMU
03/01/17
INITIATION
Target $50
NOMU
Buy
Global Blood Therapeutics initiated with a Buy at Nomura
Nomura initiated Global Blood Therapeutics with a Buy and a $50 price target.
03/15/17
CANT
03/15/17
INITIATION
CANT
Overweight
Global Blood Therapeutics initiated with an Overweight at Cantor
NVO Novo Nordisk
$34.23

0.21 (0.62%)

01/04/17
JPMS
01/04/17
DOWNGRADE
JPMS
Underweight
Novo Nordisk downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Richard Vosser downgraded Novo Nordisk yesterday to Underweight saying consensus expectations are not reflecting the potential for further pricing pressure in the U.S. The analyst has a DKR 225 price target for the shares.
02/02/17
DBAB
02/02/17
NO CHANGE
DBAB
Novo Nordisk added to short-term buy list at Deutsche Bank
03/07/17
LEHM
03/07/17
INITIATION
LEHM
Underweight
Novo Nordisk reinstated with an Underweight at Barclays
Barclays analyst Emmanuel Papadakis reinstated Novo Nordisk with an Underweight rating and DKK 210 price target. The analyst believes the valuation premium to the group is unwarranted and feels the company's 2017 guidance "does not look cautious."
03/07/17
LEHM
03/07/17
NO CHANGE
LEHM
European Pharma raised to Positive from Neutral at Barclays
Barclays analyst Emmanuel Papadakis rolled out coverage of the European Pharmaceuticals space and upgraded his sector view to Positive from Neutral. The analyst has "high conviction that the recent transformational era of R&D innovation is set to continue," which he believes will allow the sector to retain pricing power. Papadakis put Overweight ratings on AstraZeneca (AZN), Roche (RHHBY) and Shire (SHPG), with Astra his top pick. The analyst put an Equal Weight rating on GlaxoSmithKline (GSK) and Underweight ratings on Sanofi (SNY), Novartis (NVS) and Novo Nordisk (NVO).

TODAY'S FREE FLY STORIES

CPLA

Capella Education

$88.05

0.1 (0.11%)

06:43
07/25/17
07/25
06:43
07/25/17
06:43
Hot Stocks
Capella Education sees Q3 revenue 2.0%-3.0% vs. last year »

Sees Q3 consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

FBC

Flagstar Bancorp

$30.09

0.15 (0.50%)

06:42
07/25/17
07/25
06:42
07/25/17
06:42
Earnings
Flagstar Bancorp reports Q2 EPS 71c, consensus 61c »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

  • 11

    Aug

MFG

Mizuho Financial Group

06:41
07/25/17
07/25
06:41
07/25/17
06:41
Hot Stocks
Mizuho Securities to proceed with application for establishing EU subsidiary »

Mizuho Securities Co., a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPLA

Capella Education

$88.05

0.1 (0.11%)

06:41
07/25/17
07/25
06:41
07/25/17
06:41
Earnings
Capella Education reports Q2 cont ops EPS 90c, consensus 80c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

PLYM

Plymouth Industrial REIT

$17.35

0.2475 (1.45%)

06:39
07/25/17
07/25
06:39
07/25/17
06:39
Hot Stocks
Plymouth Industrial REIT to acquire Airport Business Park in Memphis for $7.8M »

Plymouth Industrial REIT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTES

NetEase

$311.50

4.3 (1.40%)

06:38
07/25/17
07/25
06:38
07/25/17
06:38
Recommendations
NetEase analyst commentary  »

NetEase price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

AXE

Anixter

$78.85

0.5 (0.64%)

06:37
07/25/17
07/25
06:37
07/25/17
06:37
Hot Stocks
Anixter sees FY17 organic sales growth up 3.0%-5.0% »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

CIT

CIT Group

$48.90

-0.09 (-0.18%)

06:36
07/25/17
07/25
06:36
07/25/17
06:36
Earnings
CIT Group reports Q2 operating EPS ex-items 68c, consensus 60c »

Reports Q2 revenue $605M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TSLA

Tesla

$342.52

14.12 (4.30%)

, FB

Facebook

$166.00

1.57 (0.95%)

06:36
07/25/17
07/25
06:36
07/25/17
06:36
Hot Stocks
Musk says Zuckerberg's knowledge of artificial intelligence 'limited' »

In response to a tweet…

TSLA

Tesla

$342.52

14.12 (4.30%)

FB

Facebook

$166.00

1.57 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 02

    Aug

  • 08

    Aug

  • 13

    Sep

  • 02

    Oct

BIIB

Biogen

$284.70

1.78 (0.63%)

06:36
07/25/17
07/25
06:36
07/25/17
06:36
Hot Stocks
Biogen announces updated strategic framework »

Biogen announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

VLKAY

Volkswagen

$32.19

-0.79 (-2.40%)

, POAHY

Porsche

$5.82

-0.03 (-0.51%)

06:35
07/25/17
07/25
06:35
07/25/17
06:35
Periodicals
VW CEO criticizes Porsche labor chief's remarks on Audi, Reuters says »

Volkswagen (VLKAY) CEO…

VLKAY

Volkswagen

$32.19

-0.79 (-2.40%)

POAHY

Porsche

$5.82

-0.03 (-0.51%)

AUDVF

Audi AG

$835.60

-4.8 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXE

Anixter

$78.85

0.5 (0.64%)

06:35
07/25/17
07/25
06:35
07/25/17
06:35
Earnings
Anixter reports Q2 adjusted EPS $1.36, consensus $1.34 »

Reports Q2 revenue $2.0B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

AEL

American Equity

$28.06

0.06 (0.21%)

06:34
07/25/17
07/25
06:34
07/25/17
06:34
Downgrade
American Equity rating change  »

American Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

TRMB

Trimble

$38.20

0.49 (1.30%)

06:34
07/25/17
07/25
06:34
07/25/17
06:34
Hot Stocks
Trimble adds first partner in Latin America to Vantage network »

Trimble announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 02

    Aug

  • 14

    Aug

SVU

Supervalu

$3.25

-0.01 (-0.31%)

06:33
07/25/17
07/25
06:33
07/25/17
06:33
Hot Stocks
Supervalu sees FY18 net earnings from continuing operations $51M-$70M »

Sees FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

BIIB

Biogen

$284.70

1.78 (0.63%)

06:33
07/25/17
07/25
06:33
07/25/17
06:33
Earnings
Biogen raises FY17 adjusted EPS view to $20.80-$21.40 from $20.45-$21.25 »

FY17 consensus $20.38.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

GPK

Graphic Packaging

$13.77

0.04 (0.29%)

06:33
07/25/17
07/25
06:33
07/25/17
06:33
Earnings
Graphic Packaging reports Q2 adj. EPS 15c, consensus 15c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

PHM

PulteGroup

$24.42

0.11 (0.45%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Hot Stocks
Breaking Hot Stocks news story on PulteGroup »

PulteGroup believes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

SVU

Supervalu

$3.25

-0.01 (-0.31%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Earnings
Supervalu reports Q1 adjusted EPS 9c, consensus 11c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MORE

Monogram Residential Trust

$11.95

0.01 (0.08%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Downgrade
Monogram Residential Trust rating change  »

Monogram Residential…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHM

PulteGroup

$24.42

0.11 (0.45%)

06:32
07/25/17
07/25
06:32
07/25/17
06:32
Earnings
PulteGroup reports Q2 adjusted EPS 47c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

TEAM

Atlassian

$36.41

0.66 (1.85%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Upgrade
Atlassian rating change  »

Atlassian upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

BIIB

Biogen

$284.70

1.78 (0.63%)

06:31
07/25/17
07/25
06:31
07/25/17
06:31
Earnings
Biogen reports Q2 adjusted EPS $5.04, consensus $4.41 »

Reports Q2 revenue $3.1B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 01

    Aug

GOOG

Alphabet

$980.34

7.42 (0.76%)

, GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Recommendations
Alphabet, Alphabet Class A analyst commentary  »

Alphabet earnings…

GOOG

Alphabet

$980.34

7.42 (0.76%)

GOOGL

Alphabet Class A

$998.31

4.47 (0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$84.74

0.08 (0.09%)

06:30
07/25/17
07/25
06:30
07/25/17
06:30
Hot Stocks
Eli Lilly will pursue new standard-of-care changing therapies in oncology »

Eli Lilly is providing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 11

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.